Offerings // SAB Biotherapeutics, Inc.

SABS offering history

Every offering-related filing in SAB Biotherapeutics, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 433 filings back to Dec 7, 2020.

Last executed offering

Mar 19, 2026

424B5 — priced deal (shares or notes)

Last registration (announced)

Dec 29, 2025

S-3 — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
Aug 21, 2026	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Mar 19, 2026	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Mar 17, 2026	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 7, 2026	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Dec 29, 2025	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Nov 12, 2025	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Sep 30, 2025	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Sep 22, 2025	S-3/A →	REGISTERED	S-3/A registration — capacity to sell shares, not a sale yet
Sep 2, 2025	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Jul 21, 2025	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jan 26, 2024	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Nov 28, 2023	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Nov 20, 2023	S-3/A →	REGISTERED	S-3/A registration — capacity to sell shares, not a sale yet
Nov 3, 2023	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Oct 2, 2023	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Aug 30, 2023	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Aug 21, 2023	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Jul 31, 2023	AW →	WITHDRAWN	Registration withdrawn
Jun 21, 2023	RW →	WITHDRAWN	Registration withdrawn
May 17, 2023	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
May 9, 2023	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
May 9, 2023	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
May 1, 2023	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Mar 24, 2023	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Mar 7, 2023	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Feb 10, 2023	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Feb 8, 2023	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Feb 3, 2023	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Dec 12, 2022	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Nov 18, 2022	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Aug 23, 2022	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
Aug 17, 2022	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jun 7, 2022	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
May 16, 2022	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Apr 29, 2022	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Apr 26, 2022	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Dec 29, 2021	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Dec 15, 2021	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Dec 3, 2021	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
Oct 28, 2021	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)

SABS offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full SABS workspace →

SABS offering FAQ

When did SABS last execute an offering?

Per SEC filings, SAB Biotherapeutics, Inc.'s most recent priced offering document is a 424B5 filed 2026-03-19. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did SABS last announce or register an offering?

The most recent registration is a S-3 filed 2025-12-29. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.

Free to use. No account, no card.